Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 13/20 | 0.56 |
| ▸ | CYP11B2 | P19099 | 13/20 | 0.56 |
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | HPGDS | O60760 | 1/20 | 0.43 |
| ▸ | LDLR | P01130 | 2/20 | 0.38 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.38 |
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
| ▸ | FNTB | P49356 | 1/20 | 0.36 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6809013 | 0.86 | CYP11B1 (0.52) | CYP11B1CYP11B2IDO1HPGDSAPP | |
| SCHEMBL3969041 | 0.86 | CYP11B1 (0.75) | CYP11B1CYP11B2IDO1HPGDS | |
| SCHEMBL1501884 | 0.85 | CYP11B1 (0.70) | CYP11B1CYP11B2IDO1HPGDSLDLR | |
| SCHEMBL7260734 | 0.82 | CYP11B1 (0.54) | CYP11B1CYP11B2IDO1HPGDSLDLR | |
| SCHEMBL1951380 | 0.77 | CYP11B1 (0.66) | CYP11B1CYP11B2IDO1HPGDSLDLR | |
| SCHEMBL15358470 | 0.76 | CYP11B1 (0.56) | CYP11B1CYP11B2IDO1HPGDSLDLR | |
| SCHEMBL15358472 | 0.74 | HSP90AA1 (0.45) | CYP11B1CYP11B2IDO1HPGDSAPP | |
| SCHEMBL6650781 | 0.73 | CYP11B1 (0.52) | CYP11B1CYP11B2IDO1HPGDSLDLR | |
| SCHEMBL1949482 | 0.72 | CYP11B1 (1.00) | CYP11B1CYP11B2IDO1HPGDS | |
| SCHEMBL1502108 | 0.71 | CYP11B1 (0.62) | CYP11B1CYP11B2IDO1HPGDSLDLR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003053941-A2 | BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-ALPHA CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-07-03 | — | — | WO | disclosed |